High risk bladder cancer: current management and survival
Author:
Affiliation:
1. University Medical Center Groningen, The Netherlands
2. Leiden University Medical Center
3. Comprehensive Cancer Center North-Netherlands, The Netherlands
Publisher
FapUNIFESP (SciELO)
Subject
Urology
Link
http://www.scielo.br/pdf/ibju/v37n2/a07v37n02.pdf
Reference29 articles.
1. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression;Bohle A;Urology,2004
2. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome;Herr HW;J Urol,2000
3. Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials;Sylvester RJ;J Urol,2005
4. Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma;Kaasinen E;Eur Urol,2002
5. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials;Sylvester RJ;J Urol.,2004
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis;Frontiers in Endocrinology;2021-10-07
2. NMIBC and Oncological Outcomes from Endoscopic Resection;Management of Non-Muscle Invasive Bladder Cancer;2019-10-24
3. Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer;Clinical Genitourinary Cancer;2018-08
4. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells;Tumor Biology;2016-09-16
5. Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo;European Journal of Pharmacology;2015-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3